Advertisement
Advertisement

GSK

GSK logo

GSK plc - ADR

49.57
USD
Sponsored
+0.53
+1.09%
Jan 02, 15:59 UTC -5
Closed
exchange

After-Market

49.66

+0.09
+0.18%

GSK Earnings Reports

Positive Surprise Ratio

GSK beat 32 of 39 last estimates.

82%

Next Report

Date of Next Report
Feb 04, 2026
Estimate for Q4 25 (Revenue/ EPS)
$8.70B
/
$0.23
Implied change from Q3 25 (Revenue/ EPS)
+1.78%
/
-58.18%
Implied change from Q4 24 (Revenue/ EPS)
+7.17%
/
--

GSK plc - ADR earnings per share and revenue

On Oct 29, 2025, GSK reported earnings of 0.55 USD per share (EPS) for Q3 25, beating the estimate of 0.48 USD, resulting in a 12.80% surprise. Revenue reached 8.55 billion, compared to an expected 8.57 billion, with a -0.28% difference. The market reacted with a +5.10% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 9 analysts forecast an EPS of 0.23 USD, with revenue projected to reach 8.70 billion USD, implying an decrease of -58.18% EPS, and increase of 1.78% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
enGene Holdings Inc. Common Stock
Report Date
Dec 22, 2025 For Q4 25
Estimate
-$0.57
Actual
-$0.73
Surprise
-25.95%
logo
Citius Oncology, Inc. Common Stock
Report Date
Dec 23, 2025 For Q4 25
Estimate
-$0.12
Actual
-$0.06
Surprise
+50.98%
FAQ
For Q3 2025, GSK plc - ADR reported EPS of $0.55, beating estimates by 12.8%, and revenue of $8.55B, -0.28% below expectations.
The stock price moved up 5.1%, changed from $43.70 before the earnings release to $45.93 the day after.
The next earning report is scheduled for Feb 04, 2026.
Based on 9 analysts, GSK plc - ADR is expected to report EPS of $0.23 and revenue of $8.70B for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement